Convulsions and Shigellosis by Lau, YL et al.
Title Convulsions and Shigellosis
Author(s) Tsang, AMC; Ting, LY; Lau, YL; Low, LCK
Citation Journal of the Hong Kong Medical Association, 1994, v. 46 n. 3,p. 239-241
Issued Date 1994
URL http://hdl.handle.net/10722/53457
Rights Creative Commons: Attribution 3.0 Hong Kong License
Convulsions and Shigellosis
A. M. C. Tsang, L. Y. Ting, Y. L. Law and L. C. K. Low
Abstract
The records of 97 children with culture-proven Shigellosis were reviewed in order to assess the
frequency and risk factors of convulsions associated with this infection. Thirteen (13.4%) had
convulsions, three of whom had additional features suggestive of encephalopathy. Clinical and
laboratory data were compared between patients with and without convulsions to define the risk
factors for the development of seizures. A high peak temperature and high band forms in excess
of 10% of the differential white cell count were significant risk factors. Age, sex, family history of
febrile seizure or epilepsy, and the Shigella strain were not significant risk factors.
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Introduction
Convulsion is among the most frequent extra-intesti-
nal manifestations of Shigellosis. It occurs in 12 to
45% of affected children,1-4 which is more frequent
than other common febrile illness. The pathogenesis
of such neurological manifestations is not clear. It has
been suggested that the factors related to the course
of disease like high fever and electrolyte disturbances5
and the production of neurotoxin by the Shigella or-
ganism may play a role.6 The aim of this retrospective
study was to review the clinical and laboratory fea-
tures of children with Shigellosis and to identify the
risk factors for the development of convulsions.
Subjects and methods
We reviewed the records of 97 children with culture-
proven Shigellosis, who were admitted into the
University Paediatric Unit of Queen Mary Hospital
between January 1987 and December 1992. The medi-
cal history, clinical and laboratory data were analysed
and compared between children with and without
convulsions. Statistical analysis were performed using
the Students' t test and chi-square test.
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Results
Thirteen (13.4%) of the 97 children with culture-proven
Shigella gastroenteritis presented with generalized tonic-
clonk convulsions within 24 hours of onset of fever.
Five of these patients did not have any diarrhoeal
symptoms before admission. The convulsions all lasted
for less than 15 minutes. Two had another attack of
convulsion (less than 15 minutes) after admission. Three
(3%) of them had drowsiness and stupor on presentation.
None had clinical signs of meningitis. Lumbar puncture
was performed in six patients (three with encephalo-
pathy, two with recurrent convulsions and one who
was seven years old which fell outside the age range for
febrile convulsion) and the cerebrospinal fluid (CSF)
findings were normal. Cultures of the CSF were all
sterile. Computerised tomography scanning of the brain
was performed in the three patients with encephalopathy
and changes of cerebral oedema was only present in
one of them. Electroencephalogram showed diffuse slow
waves changes in all three patients. They were started
empirically on intravenous Acyclovir and Cefotaxime
for suspected infectious encephalopathy. Acyclovir and
Cefotaxime were stopped when the stool culture results
were available. One seven-year-old child developed
myocarditis and heart failure in addition to encephalo-
pathy. The encephalopathic changes resolved within 24
hours after admission. All the other patients had a benign
course and recovered uneventfully after treatment.
The age distribution of the children with or with-
out convulsions is shown in Figure 1. Of the 60
children under five years of age, eight (13.3%) had
convulsion as compared to five (13.5%) of 37 children
over five years of age.
The history, clinical and laboratory data were
239
240 J Hong Kong Med Assoc Vol. 46, No. 3, September 1994
Table 1. Possible Risk factors for convulsions in 97 children with Shigellosis
Factor Children with convulsions Children without convulsions
Number
Age (years)
Family history of convulsions (%)
Individual history of febrile convulsions
M:F ratio
Temperature peak (°C)
White cell count (109/L)
Band form >10% (%)
Serum sodium (mmol/l)
Serum potassium (mmol/l)
PH
13
4.39 ± 2.97'
0
2
2.25:1
39.9 + 0.7
15.8 ±6.3
100
135.8 + 3.6
3.6 + 0.3
7.38 ± 0.05
84
4.57 ±3.54
0
0
1.27:1
38.6+ 1.1
14.1 + 8.0
32
136.6 + 4.3
3.7 + 0.5
7.38 + 0.06
NS
NS
NS
NS
< 0.0001
NS
< 0.0001
NS
NS
NS
" mean + SD
NS = not significant (p > 0.05)
compared between children with and without con-
vulsions for possible risk factors (Table 1). No
difference was found between the two groups with
respect to age, family history of febrile convulsion or
epilepsy, sex ratio, total leucocyte count, serum elec-
trolytes and pH. The mean temperature peak was
significantly higher in children with convulsions than
in those without (39.9 ± 0.7oC vs 38.6 ± 1.1°C, p <
0.0001). Among those with convulsion, only one had
a temperature below 39°C. Six (46.2%) had a tem-
perature between 39.1 to 40°C while six (46.2%) had
temperature above 40°C. Children with convulsions
had a significantly higher percentage of band forms
in their differential white cell counts (28.8 ± 10.4%, p
< 0.0001).
In the study population, 69 (71%), 27 (28%) and 1
<1 %) were infected by Shigella flexneri, Shigella sonnei
and Shigella dysenteriae respectively. Among those
with convulsions, seven were infected by Shigella
D without convulsion
• with convulsion
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Fig. 1. The age distribution of patients with or without
convulsions.
flexneri and six by Shigella sonnei. There was no
statistical significance among the different strains of
Shigella on the occurrence of convulsions (Table 2).
Discussion
Neurological symptoms are the commonest extra-in-
testinal manifestations of Shigellosis. In our series,
13.4% of the patients had convulsions and 3% had
encephalopathy. This is lower than the prevalence of
12 to 45% reported in other series.1-4 Since not all the
patients with Shigellosis are hospitalized, the true
incidence of neurological symptoms may be lower.
Young age, a history of convulsions in the patient
or family, and a high peak temperature were risk
factors that were associated with higher incidence of
convulsions in Ashkenazi's series.4 Other factors like
the serum electrolytes, blood glucose, the total white
cell counts, the absolute number of band cells, and
the species of Shigella were not important risk fac-
tors. We identified only two factors that were
associated with higher risk of convulsions: a high
peak temperature and a high band forms of greater
than 10% of the differential white cell count. 92.4%
patients with convulsions had a temperature of higher
than 39°C. All of our patients with convulsions had
greater than 10% of band forms in their differential
Table 2. Influence of Shigella strain on occurrence of
convulsions
Shigella strain
Shigella flexneri
Shigella sonnei
Shigella dysenteriae
No of
children
infected
69
27
1
No.(%) of
children with
convulsions
7 (10%)
6 (22%)
0 (0%)
P
NS
NS
NS
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white cell count. The high band forms may be an
acute stress response to the convulsion or the infec-
tion itself, as a result of epinephrine-mediated
reactions and mobilization of the immature
neutrophils into the circulation. Young age was not
an important risk factor in our series. 13.3% of chil-
dren under five years and 13.5% of children over five
years of age developed convulsions associated with
Shigella infection. In fact, 41.7% of those having con-
vulsions were older than five years of age, which fell
outside the usual age range for febrile convulsions,
with the oldest one being nine years old. A family
history of convulsions has not been found to be a
significant risk factor in our patients.
Seizure occurs more frequently in Shigellosis than
in other gastrointestinal infections. The underlying
reason is unclear. It has been attributed to the Shiga
toxin which possesses neurotoxic, cytotoxic and
enterotoxic properties but its exact role remains con-
troversial.7 Although Shiga toxin is considered to be a
neurotoxin, it does not directly invade neurons, but
damages the endothelial cells, causing vascular dis-
turbances in the brain with secondary neurological
disturbances. Recently Ashkenazi et al. found a heat-
labile cytotoxin with a molecular mass of 100 to 125
kDa produced by pathogenic Shigella species, caused
reversible neurological dysfunction in experimental
mice.8 Whether other toxic products of Shigella or-
ganisms play a role in the pathogenesis of neurological
manifestation still needs further studies.
In summary, while the pathogenesis of Shigellosis-
associated convulsions is still unclear, a high peak
temperature and high band forms in excess of 10% of
the differential leucocyte count were significant risk
factors for the development of seizures in Shigellosis.
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